M2-Type Macrophages Induce Tregs Generation by Activating the TGF-β/Smad Signalling Pathway to Promote Colorectal Cancer Development

References

• Sawicki T, Ruszkowska M, Danielewicz A, et al. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). 2021;13:2025. doi:10.3390/cancers13092025
   PubMed Web of Science ®Google Scholar
• Elia I, Haigis MC. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab. 2021;3:21–32. doi:10.1038/s42255-020-00317-z
   PubMedGoogle Scholar
• Martinez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669–680. doi:10.1038/s41568-021-00378-6
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang J, Yang C, et al. A study of the correlation between M2 macrophages and lymph node metastasis of colorectal carcinoma. World J Surg Oncol. 2021;19:91. doi:10.1186/s12957-021-02195-5
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–1437. doi:10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Wang J, Huang H, Lu J, et al. Tumor cells induced-M2 macrophage favors accumulation of Treg in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2017;10:8389–8401.
   PubMed Web of Science ®Google Scholar
• Wu Y, Yang S, Ma J, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2021:candisc.0316.2021. doi:10.1158/2159-8290.CD-21-0316
   Web of Science ®Google Scholar
• Shrivastava R, Shukla N. Attributes of alternatively activated (M2) macrophages. Life Sci. 2019;224:222–231. doi:10.1016/j.lfs.2019.03.062
   PubMed Web of Science ®Google Scholar
• Cinier J, Hubert M, Besson L, et al. Recruitment and expansion of Tregs cells in the tumor environment-how to target them? Cancers (Basel). 2021;13(8):1850. doi:10.3390/cancers13081850
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–532. doi:10.1038/nri2343
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336. doi:10.1038/ni904
   PubMed Web of Science ®Google Scholar
• Zhu Q, Wu X, Wu Y, et al. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer. Oncol Rep. 2016;36:3472–3478. doi:10.3892/or.2016.5136
   PubMed Web of Science ®Google Scholar
• Sun W, Wei FQ, Li WJ, et al. A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma. Br J Cancer. 2017;117:1631–1643. doi:10.1038/bjc.2017.329
   PubMed Web of Science ®Google Scholar
• Erlandsson A, Carlsson J, Lundholm M, et al. M2 macrophages and regulatory T cells in lethal prostate cancer. Prostate. 2019;79:363–369. doi:10.1002/pros.23742
   PubMed Web of Science ®Google Scholar
• Zhang N, Ng AS, Cai S, et al. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22:e358–e368. doi:10.1016/S1470-2045(21)00343-0
   PubMed Web of Science ®Google Scholar
• Derynck R, Muthusamy BP, Saeteurn KY. Signaling pathway cooperation in TGF-beta-induced epithelial-mesenchymal transition. Curr Opin Cell Biol. 2014;31:56–66. doi:10.1016/j.ceb.2014.09.001
   PubMed Web of Science ®Google Scholar
• Wang X, Lai Q, He J, et al. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-beta/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 2019;16:51–59. doi:10.7150/ijms.27359
   PubMed Web of Science ®Google Scholar
• Liu Z, Kuang W, Zhou Q, et al. TGF-beta1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway. Int J Mol Med. 2018;42:3395–3403. doi:10.3892/ijmm.2018.3923
   PubMed Web of Science ®Google Scholar
• Cai J, Xia L, Li J, et al. Tumor-associated macrophages derived TGF-betaInduced epithelial to mesenchymal transition in colorectal cancer cells through Smad2,3-4/Snail signaling pathway. Cancer Res Treat. 2019;51:252–266. doi:10.4143/crt.2017.613
   PubMed Web of Science ®Google Scholar
• Anthoni M, Fyhrquist-Vanni N, Wolff H, et al. Transforming growth factor-beta/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity. Br J Dermatol. 2008;159:546–554. doi:10.1111/j.1365-2133.2008.08696.x
   PubMed Web of Science ®Google Scholar
• Tone Y, Furuuchi K, Kojima Y, et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9:194–202. doi:10.1038/ni1549
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11:723–737. doi:10.1038/nri3073
   PubMed Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425–6440. doi:10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Xue T, Yan K, Cai Y, et al. Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer. World J Surg Oncol. 2021;19:186. doi:10.1186/s12957-021-02299-y
   PubMed Web of Science ®Google Scholar
• Sundstrom P, Stenstad H, Langenes V, et al. Regulatory T cells from colon cancer patients inhibit effector T-cell migration through an adenosine-dependent mechanism. Cancer Immunol Res. 2016;4:183–193. doi:10.1158/2326-6066.CIR-15-0050
   PubMed Web of Science ®Google Scholar
• David CJ, Massague J. Contextual determinants of TGFbeta action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19:419–435. doi:10.1038/s41580-018-0007-0
   PubMed Web of Science ®Google Scholar
• Hao Y, Baker D, Ten Dijke P. TGF-beta-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767. doi:10.3390/ijms20112767
   PubMed Web of Science ®Google Scholar
• Gupta S, Maitra A. EMT: matter of life or death? Cell. 2016;164:840–842. doi:10.1016/j.cell.2016.02.024
   PubMed Web of Science ®Google Scholar
• Massague J. TGFbeta in Cancer. Cell. 2008;134:215–230. doi:10.1016/j.cell.2008.07.001
   PubMed Web of Science ®Google Scholar
• Chen HY, Chiang YF, Huang JS, et al. Isoliquiritigenin reverses epithelial-mesenchymal transition through modulation of the TGF-beta/Smad signaling pathway in endometrial cancer. Cancers (Basel). 2021;13. doi:10.3390/cancers13061236
   Web of Science ®Google Scholar
• Shi Y, Wang YF, Jayaraman L, et al. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell. 1998;94:585–594. doi:10.1016/s0092-8674(00)81600-1
   PubMed Web of Science ®Google Scholar
• Chen Y, Xing P, Chen Y, et al. High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer. World J Surg Oncol. 2014;12:328. doi:10.1186/1477-7819-12-328
   PubMed Web of Science ®Google Scholar
• Li Q, Dai W, Li Y, et al. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep. 2017;7:46345. doi:10.1038/srep46345
   PubMed Web of Science ®Google Scholar
• Sun SW, Chen L, Zhou M, et al. BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-beta pathway in chronic obstructive pulmonary disease. Respir Res. 2019;20:26. doi:10.1186/s12931-019-0988-z
   PubMed Web of Science ®Google Scholar